MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Phase 2
Completed
Conditions
Lung Cancer
Lung Metastases
Interventions
First Posted Date
2015-07-14
Last Posted Date
2024-04-16
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
33
Registration Number
NCT02496585
Locations
🇺🇸

Memorial Sloan Kettering Nassau, Uniondale, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 9 locations

Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

Phase 1
Active, not recruiting
Conditions
Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2015-07-10
Last Posted Date
2024-07-29
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
12
Registration Number
NCT02494882
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Not Applicable
Active, not recruiting
Conditions
High Risk for Developing Breast Cancer
Interventions
Behavioral: Nonlinear Aerobic Training
Other: Height, Weight, BMI measure
Other: Blood draw
Other: Cardiopulmonary exercise test
First Posted Date
2015-07-10
Last Posted Date
2024-08-29
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
75
Registration Number
NCT02494869
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)

Not Applicable
Completed
Conditions
Upper Extremity Lymphedema
Breast Cancer
Interventions
Drug: QBX258
First Posted Date
2015-07-10
Last Posted Date
2018-11-08
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
9
Registration Number
NCT02494206
Locations
🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

Not Applicable
Completed
Conditions
Epithelial Ovarian Cancer
Interventions
Device: Mirena® intra-uterine device (IUD)
First Posted Date
2015-06-22
Last Posted Date
2023-10-16
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
7
Registration Number
NCT02477202
Locations
🇺🇸

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Not Applicable
Withdrawn
Conditions
Metastatic Disease to Bone
Metastatic Disease to Soft Tissue
Interventions
Device: MRI with IVIM DW-MRI
Other: Blood draw
First Posted Date
2015-06-08
Last Posted Date
2016-09-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Registration Number
NCT02465723
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

Active, not recruiting
Conditions
Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
Interventions
Device: MRI
Behavioral: Optional Screening Questionnaire
First Posted Date
2015-06-04
Last Posted Date
2024-07-16
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
63
Registration Number
NCT02462460
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Irreversible Electroporation Ablation for Colorectal Metastases to the Lung

Not Applicable
Completed
Conditions
Colorectal Metastases to the Lung
Interventions
Device: Irreversible Electroporation Ablation
First Posted Date
2015-06-03
Last Posted Date
2018-01-08
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
2
Registration Number
NCT02461550
Locations
🇺🇸

Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States

🇺🇸

Memorial Sloan Kettering West Harrison, Harrison, New York, United States

and more 1 locations

Identifying Family Members in Need of Support While Caregiving and After Loss

Active, not recruiting
Conditions
Advanced Cancer
Interventions
Behavioral: background questionnaire
Behavioral: bereavement risk screening tool
First Posted Date
2015-05-28
Last Posted Date
2024-05-29
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
52
Registration Number
NCT02455505
Locations
🇺🇸

Calvary Hospital, Bronx, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Not Applicable
Completed
Conditions
Oligometastatic Lung Adenocarcinoma
Interventions
Drug: Erlotinib
Other: Local Therapies
First Posted Date
2015-05-21
Last Posted Date
2018-05-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
4
Registration Number
NCT02450591
Locations
🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

🇺🇸

Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath